NovioGendix noviogendix.com


NovioGendix is a privately-held molecular diagnostics company focused on the development of a non-invasive liquid biopsy test for prostate cancer.

NovioGendix is a privately-held molecular diagnostics company focused on the development of a non-invasive liquid biopsy test for prostate cancer.

Company (Acquired)

Phone: +31 24 327 9494

Fax:

Postbus 9101

Nijmegen, 6500
Netherlands

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NovioGendix $0M Sep 15, 2015
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NovioGendix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
BioGeneration VenturesVenture CapitalNaarden, NetherlandsSeries A
PPM OostVenture CapitalArnhem, NetherlandsSeries A
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Molecular markers in bladder cancer Mar 07, 2014 Application
Combinations of molecular markers in prostate cancer providing a diagnostic tool with improved sensitivity/specificity Nov 02, 2012 Application
Molecular markers in prostate cancer May 09, 2012 Application